omeprazole has been researched along with gyki 52466 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrási, F; Berzsenyi, P; Botka, P; Farkas, L; Hámori, T; Körösi, J; Láng, T; Ling, I | 1 |
1 other study(ies) available for omeprazole and gyki 52466
| Article | Year |
|---|---|
Omeprazole and talampanel as two examples of retrometabolic drug design.
Topics: Anticonvulsants; Benzodiazepines; Drug Design; Enzyme Inhibitors; Indicators and Reagents; Omeprazole; Proton Pump Inhibitors; Structure-Activity Relationship | 2004 |